<%BANNER%>

Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report

PRIVATE ITEM Digitization of this item is currently in progress.

Material Information

Title:
Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report
Physical Description:
Mixed Material
Language:
English
Creator:
Arakawa, Maki
Nakamura, Kogenta
Yamada, Yoshiaki
Rosser, Charles J.
Tobiume, Motoi
Saito, Hiroko
Hasegawa, Takaaki
Honda, Nobuaki
Publisher:
Bio-Med Central ( BMC Urology)
Publication Date:

Notes

Abstract:
Background: Gefitinib remains an excellent treatment option for patients with a variety of cancers, including non small cell lung cancer (NSCLC). However, clinicians must be aware of the potential of gefitinib to cause an inflammatory reaction in the skin, lungs and bladder. Case Presentation: We present a case on hemorrhagic cystitis and severaly contracted bladder in a patient with NSCLC on gefitinib. Conclusions: Further studies are needed to substantiate the association of gefitinib therapy with hemorrhagic cystitis and contracted bladder.
General Note:
Arakawa et al. BMC Urology 2010, 10:6 http://www.biomedcentral.com/1471-2490/10/6; Pages 1-3
General Note:
doi:10.1186/1471-2490-10-6 Cite this article as: Arakawa et al.: Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report. BMC Urology 2010 10:6.

Record Information

Source Institution:
University of Florida
Holding Location:
University of Florida
Rights Management:
All rights reserved by the source institution.
Resource Identifier:
oclc -
System ID:
AA00018759:00001

Material Information

Title:
Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report
Physical Description:
Mixed Material
Language:
English
Creator:
Arakawa, Maki
Nakamura, Kogenta
Yamada, Yoshiaki
Rosser, Charles J.
Tobiume, Motoi
Saito, Hiroko
Hasegawa, Takaaki
Honda, Nobuaki
Publisher:
Bio-Med Central ( BMC Urology)
Publication Date:

Notes

Abstract:
Background: Gefitinib remains an excellent treatment option for patients with a variety of cancers, including non small cell lung cancer (NSCLC). However, clinicians must be aware of the potential of gefitinib to cause an inflammatory reaction in the skin, lungs and bladder. Case Presentation: We present a case on hemorrhagic cystitis and severaly contracted bladder in a patient with NSCLC on gefitinib. Conclusions: Further studies are needed to substantiate the association of gefitinib therapy with hemorrhagic cystitis and contracted bladder.
General Note:
Arakawa et al. BMC Urology 2010, 10:6 http://www.biomedcentral.com/1471-2490/10/6; Pages 1-3
General Note:
doi:10.1186/1471-2490-10-6 Cite this article as: Arakawa et al.: Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report. BMC Urology 2010 10:6.

Record Information

Source Institution:
University of Florida
Holding Location:
University of Florida
Rights Management:
All rights reserved by the source institution.
Resource Identifier:
oclc -
System ID:
AA00018759:00001